Increased IGFBP proteolysis, IGF-I bioavailability and pappalysin levels in children with Prader-Willi syndrome
CONCLUSION: The increase in PAPP-A could be involved in increased IGFBP proteolysis, promoting IGF-I bioavailability in children with PWS. Further studies are needed to establish the relationship between growth, GH resistance, and changes in the IGF axis during development and after GH treatment in these patients.PMID:38141219 | DOI:10.1210/clinem/dgad754
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Vicente Barrios Álvaro Martín-Rivada Gabriel Á Martos-Moreno Sandra Canelles Francisca Moreno-Maci án Carmen De Mingo-Alemany Maurizio Delvecchio Roberta Pajno Danilo Fintini Julie A Chowen Jes ús Argente Source Type: research
More News: Child Development | Children | Endocrinology | Hormones | Insulin | Prader-Willi Syndrome | Study